Table 1.
The relationship between MALAT1 expression and clinicopathological feature of gastric cancer patients
| Variables | Number | MALAT1 expression | P-value | |
|---|---|---|---|---|
| Low | High | |||
| Age (years) | 0.071 | |||
| <65 | 24 | 3 (12.5) | 21 (87.5) | |
| ≥65 | 23 | 8 (34.8) | 15 (65.2) | |
| Sex | 0.725 | |||
| Male | 32 | 7 (21.9) | 25 (78.1) | |
| Female | 15 | 4 (26.7) | 11 (73.3) | |
| Depth of tumor invasion | 0.039 | |||
| T1 ~ T2 | 10 | 5 (50.0) | 5 (50.0) | |
| T3 ~ T4 | 37 | 6 (16.2) | 31 (83.8) | |
| Lymph node metastasis | 0.472 | |||
| Absent | 16 | 5 (31.3) | 11 (68.8) | |
| Present | 31 | 6 (19.4) | 25 (80.6) | |
| Stage | 0.505 | |||
| I, II | 21 | 6 (28.6) | 15 (71.4) | |
| III | 26 | 5 (19.2) | 21 (80.8) | |
| Lauren’s classification | 0.242 | |||
| Intestinal | 27 | 9 (33.3) | 18 (66.7) | |
| Diffuse | 18 | 2 (11.1) | 16 (88.9) | |
| Mixed | 2 | 0 (0.0) | 2 (100.0) | |
| Differentiation | 0.030 | |||
| Well to moderate | 25 | 9 (36.0) | 16 (64.0) | |
| Poorly or signet ring cell | 22 | 2 (9.1) | 20 (90.9) | |
| Serum CEA value | >0.999 | |||
| ≤5 | 37 | 9 (24.3) | 28 (75.7) | |
| >5 | 10 | 2 (20.0) | 8 (80.0) | |
| Serum CA19-9 value | 0.614 | |||
| ≤37 | 41 | 9 (22.0) | 32 (78.0) | |
| >37 | 6 | 2 (33.3) | 4 (66.7) | |